Oritavancin activity tested against European staphylococcal clinical isolates and resistant subsets inlcuding those with reduced susceptibility to daptomycin, teicoplanin or vancomycin (2010-2014)
Oritavancin activity tested against European staphylococcal clinical isolates and resistant subsets inlcuding those with reduced susceptibility to daptomycin, teicoplanin or vancomycin (2010-2014), Lead author: Mendes RE, presented at 26th annual European Congress of Clinical Microbiology and Infectious Diseases (ECCMID), April 9-12, 2016, Amsterdam, Netherlands
